{"rows":[{"id":5554,"title":"Psilocybin-induced Autonomic, Perceptual, and Behavioral Change","authors":"R Fischer, Diana Warshay","journal":"Pharmacopsychiatry","publication_date":"1968-11-01","publication_year":1968,"doi":"10.1055/s-0028-1094227","pubmed_id":null,"openalex_id":"https://openalex.org/W2047529423","source_url":"https://doi.org/10.1055/s-0028-1094227","substance_tags":"psilocybin","topic_tags":"Depression,Anxiety,Receptor Pharmacology,Personality Change","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:09","last_checked":"2026-08-09 08:25:58","bibtex":null,"source_record_id":"DOI:10.1055/s-0028-1094227","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1055/s-0028-1094227","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1055/s-0028-1094227","source_url":"https://doi.org/10.1055/s-0028-1094227","doi":"10.1055/s-0028-1094227","pmid":"","publication_date":"1968-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5545,"title":"Hypnotic Induction of the Interference of Psilocybin with Optically Induced Spatial Distortion","authors":"Peter Gwynne, Roland Fischer, Richard Hill","journal":"Pharmacopsychiatry","publication_date":"1969-11-01","publication_year":1969,"doi":"10.1055/s-0028-1094250","pubmed_id":null,"openalex_id":"https://openalex.org/W2023363612","source_url":"https://doi.org/10.1055/s-0028-1094250","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology,Personality Change","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:09","last_checked":"2026-08-09 08:25:58","bibtex":null,"source_record_id":"DOI:10.1055/s-0028-1094250","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1055/s-0028-1094250","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1055/s-0028-1094250","source_url":"https://doi.org/10.1055/s-0028-1094250","doi":"10.1055/s-0028-1094250","pmid":"","publication_date":"1969-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5541,"title":"Psilocybin-Induced Transformations of Visual Space","authors":"Richard Hill, Roland A. Fischer","journal":"Pharmacopsychiatry","publication_date":"1970-07-01","publication_year":1970,"doi":"10.1055/s-0028-1094281","pubmed_id":null,"openalex_id":"https://openalex.org/W1996705795","source_url":"https://doi.org/10.1055/s-0028-1094281","substance_tags":"psilocybin","topic_tags":"Pharmacology,Receptor Pharmacology,Toxicity","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:09","last_checked":"2026-08-09 08:25:58","bibtex":null,"source_record_id":"DOI:10.1055/s-0028-1094281","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1055/s-0028-1094281","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1055/s-0028-1094281","source_url":"https://doi.org/10.1055/s-0028-1094281","doi":"10.1055/s-0028-1094281","pmid":"","publication_date":"1970-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":5407,"title":"Psychopathological effects of S-ketamine and dimethyltryptamine (DMT) in humans: a double-blind, cross-over human experimental study of the NMDA antagonist and the 5HT2A agonist model of psychosis","authors":"Euphrosyne Gouzoulis-Mayfrank, Anna Neukirch, Karsten Heekeren","journal":"Pharmacopsychiatry","publication_date":"2005-09-01","publication_year":2005,"doi":"10.1055/s-2005-918695","pubmed_id":null,"openalex_id":"https://openalex.org/W2331400020","source_url":"https://doi.org/10.1055/s-2005-918695","substance_tags":"psilocybin","topic_tags":"Depression,Pharmacology,Receptor Pharmacology,Healthy Volunteers","study_type":"Other","source_name":"OpenAlex","publication_status":"published","date_added":"2026-07-04 06:52:06","last_checked":"2026-08-09 08:25:55","bibtex":null,"source_record_id":"DOI:10.1055/s-2005-918695","abstract_available":true,"abstract_source":"OpenAlex","abstract_source_url":"https://doi.org/10.1055/s-2005-918695","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"OpenAlex","source_record_id":"DOI:10.1055/s-2005-918695","source_url":"https://doi.org/10.1055/s-2005-918695","doi":"10.1055/s-2005-918695","pmid":"","publication_date":"2005-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2759,"title":"Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research.","authors":"Vollenweider FX","journal":"Pharmacopsychiatry","publication_date":"1998-07-01","publication_year":1998,"doi":"10.1055/s-2007-979353","pubmed_id":"9754840","openalex_id":"https://openalex.org/W2078297889","source_url":"https://pubmed.ncbi.nlm.nih.gov/9754840/","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Animal Study,Drug Interactions","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:30","bibtex":null,"source_record_id":"PMID:9754840","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/9754840/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:9754840","source_url":"https://pubmed.ncbi.nlm.nih.gov/9754840/","doi":"10.1055/s-2007-979353","pmid":"9754840","publication_date":"1998-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2758,"title":"Methodological issues of human experimental research with hallucinogens.","authors":"Gouzoulis-Mayfrank E, Schneider F, Friedrich J, Spitzer M, Thelen B, Sass H","journal":"Pharmacopsychiatry","publication_date":"1998-07-01","publication_year":1998,"doi":"10.1055/s-2007-979356","pubmed_id":"9754843","openalex_id":"https://openalex.org/W2064627176","source_url":"https://pubmed.ncbi.nlm.nih.gov/9754843/","substance_tags":"psilocybin","topic_tags":"General","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:30","bibtex":null,"source_record_id":"PMID:9754843","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/9754843/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:9754843","source_url":"https://pubmed.ncbi.nlm.nih.gov/9754843/","doi":"10.1055/s-2007-979356","pmid":"9754843","publication_date":"1998-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2687,"title":"Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers.","authors":"Gouzoulis-Mayfrank E, Heekeren K, Neukirch A, Stoll M, Stock C, Obradovic M, Kovar KA","journal":"Pharmacopsychiatry","publication_date":"2005-11-01","publication_year":2005,"doi":"10.1055/s-2005-916185","pubmed_id":"16342002","openalex_id":"https://openalex.org/W2044783071","source_url":"https://pubmed.ncbi.nlm.nih.gov/16342002/","substance_tags":"psilocybin","topic_tags":"Receptor Pharmacology,Healthy Volunteers","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:29","bibtex":null,"source_record_id":"PMID:16342002","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/16342002/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:16342002","source_url":"https://pubmed.ncbi.nlm.nih.gov/16342002/","doi":"10.1055/s-2005-916185","pmid":"16342002","publication_date":"2005-11-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2148,"title":"Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.","authors":"Mertens LJ, Preller KH","journal":"Pharmacopsychiatry","publication_date":"2021-07-01","publication_year":2021,"doi":"10.1055/a-1341-1907","pubmed_id":"33472250","openalex_id":"https://openalex.org/W3124059976","source_url":"https://pubmed.ncbi.nlm.nih.gov/33472250/","substance_tags":"psilocybin","topic_tags":"Depression,Addiction,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety","study_type":"Randomized Controlled Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:33472250","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33472250/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33472250","source_url":"https://pubmed.ncbi.nlm.nih.gov/33472250/","doi":"10.1055/a-1341-1907","pmid":"33472250","publication_date":"2021-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":2146,"title":"The Potential Role of Psychedelic Drugs in Mental Health Care of the Future.","authors":"Gründer G, Jungaberle H","journal":"Pharmacopsychiatry","publication_date":"2021-07-01","publication_year":2021,"doi":"10.1055/a-1486-7386","pubmed_id":"33979868","openalex_id":"https://openalex.org/W3162909048","source_url":"https://pubmed.ncbi.nlm.nih.gov/33979868/","substance_tags":"psilocybin","topic_tags":"Pharmacology,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:54:14","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:33979868","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/33979868/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:33979868","source_url":"https://pubmed.ncbi.nlm.nih.gov/33979868/","doi":"10.1055/a-1486-7386","pmid":"33979868","publication_date":"2021-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1911,"title":"Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.","authors":"Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR","journal":"Pharmacopsychiatry","publication_date":"2021-09-01","publication_year":2021,"doi":"10.1055/a-1524-2794","pubmed_id":"34348413","openalex_id":"https://openalex.org/W3160183306","source_url":"https://pubmed.ncbi.nlm.nih.gov/34348413/","substance_tags":"psilocybin","topic_tags":"Depression,Safety","study_type":"Other","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:06","last_checked":"2026-08-09 08:28:22","bibtex":null,"source_record_id":"PMID:34348413","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/34348413/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:34348413","source_url":"https://pubmed.ncbi.nlm.nih.gov/34348413/","doi":"10.1055/a-1524-2794","pmid":"34348413","publication_date":"2021-09-01","importer_version":"2.1.3","text_redistributed":false}},{"id":1746,"title":"Novel Antidepressants in the Pipeline (Phase II and III): A Systematic Review of the US Clinical Trials Registry.","authors":"Sakurai H, Yonezawa K, Tani H, Mimura M, Bauer M, Uchida H","journal":"Pharmacopsychiatry","publication_date":"2022-07-01","publication_year":2022,"doi":"10.1055/a-1714-9097","pubmed_id":"35045580","openalex_id":null,"source_url":"https://pubmed.ncbi.nlm.nih.gov/35045580/","substance_tags":"psilocybin","topic_tags":"Depression,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:05","last_checked":"2026-08-09 08:28:19","bibtex":null,"source_record_id":"PMID:35045580","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/35045580/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:35045580","source_url":"https://pubmed.ncbi.nlm.nih.gov/35045580/","doi":"10.1055/a-1714-9097","pmid":"35045580","publication_date":"2022-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":633,"title":"Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis.","authors":"Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ","journal":"Pharmacopsychiatry","publication_date":"2025-07-01","publication_year":2025,"doi":"10.1055/a-2529-7029","pubmed_id":"40245934","openalex_id":"https://openalex.org/W4409534321","source_url":"https://pubmed.ncbi.nlm.nih.gov/40245934/","substance_tags":"psilocybin,psilocin","topic_tags":"Depression,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression,Safety,Drug Interactions","study_type":"Clinical Trial","source_name":"PubMed","publication_status":"published","date_added":"2026-07-01 06:48:04","last_checked":"2026-08-09 08:27:58","bibtex":null,"source_record_id":"PMID:40245934","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/40245934/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:40245934","source_url":"https://pubmed.ncbi.nlm.nih.gov/40245934/","doi":"10.1055/a-2529-7029","pmid":"40245934","publication_date":"2025-07-01","importer_version":"2.1.3","text_redistributed":false}},{"id":250,"title":"Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease.","authors":"Xu T, Wong S, Le GH, Dri CE, Teopiz KM, Lu A, Lee S, Rhee TG, Yin L, Bargiota S, Ho R, McIntyre RS","journal":"Pharmacopsychiatry","publication_date":"2026-03-01","publication_year":2026,"doi":"10.1055/a-2794-6487","pubmed_id":"41643722","openalex_id":"https://openalex.org/W7128030169","source_url":"https://pubmed.ncbi.nlm.nih.gov/41643722/","substance_tags":"psilocybin","topic_tags":"Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Animal Study,In Vitro Study,Safety","study_type":"Systematic Review","source_name":"PubMed","publication_status":"published","date_added":"2026-06-30 22:38:07","last_checked":"2026-08-09 08:27:52","bibtex":null,"source_record_id":"PMID:41643722","abstract_available":true,"abstract_source":"PubMed","abstract_source_url":"https://pubmed.ncbi.nlm.nih.gov/41643722/","abstract_redistributed":false,"text_rights_status":"unverified_not_redistributed","text_license_uri":null,"source_provenance":{"source_name":"PubMed","source_record_id":"PMID:41643722","source_url":"https://pubmed.ncbi.nlm.nih.gov/41643722/","doi":"10.1055/a-2794-6487","pmid":"41643722","publication_date":"2026-03-01","importer_version":"2.1.3","text_redistributed":false}}],"total":13,"page":1,"per_page":20,"pages":1,"resource":"papers","filters":{"q":null,"author":null,"substances":["psilocybin","psilocin"],"topic":null,"study_type":null,"cited_doi":null,"sources":[],"publication_statuses":[],"year":null,"journal":"Pharmacopsychiatry","from":null,"to":null,"added_from":null,"added_to":null,"sort":"newly_added","page":1,"per_page":"20"}}